4//SEC Filing
Landau Jeffrey B 4
Accession 0001610717-24-000175
CIK 0001501989other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:36 PM ET
Size
6.1 KB
Accession
0001610717-24-000175
Insider Transaction Report
Form 4
Landau Jeffrey B
Chief Business Officer
Transactions
- Sale
Common Stock
2024-03-19$2.09/sh−6,562$13,685→ 110,060 total
Holdings
- 4,500(indirect: By IRA)
Common Stock
- 3,180(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 64,802 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001918615
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:36 PM ET
- Size
- 6.1 KB